# Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes

> **NCT04316780** · — · COMPLETED · sponsor: **Steward St. Elizabeth's Medical Center of Boston, Inc.** · enrollment: 320 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **OTHER:** Retrospective observational study- no intervention to occur.

## Key facts

- **NCT ID:** NCT04316780
- **Lead sponsor:** Steward St. Elizabeth's Medical Center of Boston, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-15
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-03-01
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2021-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04316780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04316780, "Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04316780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*